Global Blood Banking and Blood Products Market to Reach $32.3 Billion by 2010, According to New Report by Global Industry Analysts, Inc.
 |
| Press Release Attachment |
|
|
|
|
Worldwide market for blood banking and blood products is exhibiting a healthy trend, driven by an ageing population, and increase in healthcare expenditures. New infections continue to take a toll of population, fueling the demand for safe blood transfusion. Amid the scenario, global blood banking and blood products market is projected to reach about $32.3 billion by 2010. San Jose, CA (PRWEB) November 3, 2008 -- A spurt in new infections surfacing the world over remains a huge concern to the blood banking and blood products industry. Though awareness amongst the consumers, and health workers helped in reducing the intensity of infection, the industry is yet to free itself of the various problems such as safety, and availability of quality blood. The awareness has also resulted in the implementation of stringent safety standards for both donors, and blood screening (blood) banks to be adhered to before any transfusion. Rigorous testing and screening procedures, along with the help of new technology have sufficiently reduced the threat of diseases being transmitted through transfusions. Though the overall situation improved, instances of diseases spreading through blood transfusion are still common in the developing, and under-developed countries. Awareness campaigns in these countries have also drawn flak, with only a few donors volunteering.
Much of the growth in the global blood banking and blood products market (http://www.strategyr.com/Blood_Banking_and_Blood_Products_Market_Report.asp) is anticipated from the United States and Europe, as stated in a recent report published by Global Industry Analysts, Inc. The two regions collectively account for over 63% of the global market. The Asia-Pacific blood banking and blood products market, excluding Japan, is projected to grow at a CAGR of 4.9% over the period 2008-2012. In terms of product segment, blood components and plasma products market (http://www.strategyr.com/Blood_Banking_and_Blood_Products_Market_Report.asp) is the largest with an estimated share of 79% in 2008. The segment is also projected to be the fastest growing with a CAGR of 4.3% over 2008-2012.
Automated blood collection and processing systems and unraveling prion-screening abilities of new assays are set to revolutionize the blood safety setup, both by increasing the blood quality and the quantity of blood collected through painless and sophisticated instruments. Several modifications in the purchasing system in the European market have provided hospitals with more bargaining power. Whole blood & cellular components market (http://www.strategyr.com/Blood_Banking_and_Blood_Products_Market_Report.asp) in Europe is estimated at $3.3 billion in 2008.
These and other market data and trends are presented in "Blood Banking and Blood Products: A Global Strategic Business Report" published by Global Industry Analysts, Inc. This GIA report discusses the prevailing trends, issues, demand forecasts, and activities that affect the industry. The report analyzes the market in Millions of US dollars by the following geographic regions - United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World; and product group/segments - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables. Analytics for the period 1991-2015 provide a comprehensive understanding of the market.
The report profiles key blood banks in major regions of the world. Leading blood banks and players in the blood bank technology and supplies market, profiled in the report include AABB, America's Blood Centers, American Red Cross, Canadian Blood Services, CorCell Companies, Japan Red Cross, Lifebank, National Blood Foundation, New York Blood Center, Beckman Coulter, Becton Dickinson and Company, BioMerieux SA, Caridian BCT, Inc., Chiron, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Fresenius SE, Gambro AB, Haemonetics Corp., Immucor Inc., Kawasumi Laboratories, Inc., Terumo Corporation, Baxter International, CSL Limited, Grifols, Kedrion, and Octapharma, among several others. The study enumerates recent developments, mergers, acquisitions, and other strategic industry activities, and is an easy guide to What, Why, When, How, Where, and Who of the industry.
For more details about this research report, please visit http://www.strategyr.com/Blood_Banking_and_Blood_Products_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (http://www.StrategyR.com/) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ strategyR.com
Web Site http://www.StrategyR.com/
###
Simillar Articles
|
